Bone marrow cancer drug molecule

Bone marrow cancer drug molecule

C002/9211 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 69.2MB

Downloadable file size: 348.0KB

Price image Pricing

Please login to use the price calculator


Caption: Bone marrow cancer drug molecule. Molecular model of lenalidomide, a drug used to treat myeloma, a form of bone marrow cancer. The chemical formula is C13.H13.N3.O3. Atoms are colour-coded: carbon (black), hydrogen (grey), nitrogen (blue) and oxygen (red). Lenalidomide, first introduced in 2004, is manufactured and marketed by Celgene. It is also known as CC-5013, and is marketed as Revlimid.

Release details: Model release not available. Property release not required.

Keywords: 1, atoms, biochemical, biochemistry, bone marrow cancer, cc-5013, chemical, chemistry, chemotherapy, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, drug, lenalidomide, medical, medicine, molecular, molecular model, molecule, multiple myeloma, myeloma, oncology, one, organic chemistry, pharmacological, pharmacology, revlimid, single, treatment, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.